16.07.2007 | Lesedauer: ca. 3 Minuten |
[Die folgende Meldung liegt nur in englischer Sprache vor]
Huntsman Agrees to Be Acquired By Hexion for $28.00 Per Share Terminates Merger Agreement With Basell Huntsman Corporation (www.huntsman.com) announced shortly that it has terminated the merger agreement with Basell AF ("Basell", www.basell.com) dated June 26, 2007 (the "Basell Agreement") and has agreed to a definitive merger agreement (the "Hexion Agreement") with Hexion Specialty Chemicals, Inc. ("Hexion", www.hexionchem.com), an Apollo Management, L.P. ("Apollo") portfolio company, pursuant to which Hexion will acquire Huntsman in a transaction with a total value of approximately $10.6 billion, including the assumption of debt (the "Hexion Transaction"). Under the terms of the agreement, Hexion will acquire all of the outstanding common stock of Huntsman for $28.00 per share in cash. The agreement also provides that the cash price per share to be paid by Hexion will increase at the rate of 8% per annum (inclusive of any dividends paid) beginning 270 days from July 12, 2007. The Hexion Transaction was deemed to be a superior proposal to the Basell Agreement and was unanimously approved by the Board of Directors of Huntsman. Huntsman´s Board of Directors approved the agreement for the Hexion Transaction at the recommendation of a Transaction Committee comprised solely of Huntsman independent directors. Hexion´s Board of Directors also has approved the agreement. The transaction is subject to customary closing conditions, including regulatory approval in the U.S. and in Europe, as well as the approval of Huntsman shareholders. Entities controlled by MatlinPatterson and the Huntsman family and a Huntsman charitable trust, who collectively own approximately 57% of Huntsman´s common stock, have agreed to vote in favor of the transaction. The transaction is not subject to a financing condition and commitments have been obtained by Hexion for all necessary debt financing from affiliates of Credit Suisse and Deutsche Bank AG. Hexion will have up to 12 months, subject to a 90 day extension by the Huntsman Board of Directors under certain circumstances, to close the transaction. Huntsman´s Board of Directors authorized the delivery of a notice of termination of the Basell Agreement, along with the payment of the $200 million break-up fee required by the Basell Agreement. Hexion funded $100 million of the Basell break-up fee while Huntsman funded the remaining $100 million. Peter R. Huntsman, President and CEO of Huntsman, said: "This is a very favorable outcome for our shareholders and one that reflects a confidence in our Company of which our associates can be very proud. Hexion is an attractive candidate for a merger with Huntsman. We have complementary businesses and, together, will have an even stronger technology platform from which to serve our customers." Jon M. Huntsman, Founder and Chairman of Huntsman, added: "I have invested much of my life in Huntsman Corporation and consider it the highest honor to be associated with such exceptional customers and associates. However, the time has come when it is in the best interests of our shareholders to sell the Company. I am pleased with the outcome of our merger negotiations with Apollo, and have every confidence that the combined Hexion and Huntsman teams will be superb stewards of this business for the next era." Huntsman will file a Form 8-K with the U.S. Securities and Exchange Commission (the "SEC") with further details concerning this transaction, including a copy of the Hexion merger agreement. Merrill Lynch & Co. and Cowen and Company, LLC acted as financial advisors to Huntsman. Vinson & Elkins L.L.P. and Shearman and Sterling LLP acted as legal advisors to Huntsman. |
Huntsman Corporation, The Woodlands, Texas and Salt Lake City
» insgesamt 32 News über "Huntsman Corporation" im News-Archiv gefunden
Ihre News im plasticker? Bitte senden Sie Ihre Pressemitteilungen an redaktion@plasticker.de!
» zurück zum Seitenanfang |
Top-Meldungen der letzten Tage
Amcor: Verpackungsmittelkonzern übernimmt Berry Global
Voelpker: Neuer Formaldehyd-Fänger - Unterdrückung von Kettenabbau und Formaldehydfreisetzung
Starlinger: Übernahme der Gewebesparte von Windmöller & Hölscher
Engel: „foammelt Days 2024“ am 27. und 28. November in Schwertberg - Schaumspritzgießen von A bis Z
Meist gelesen, 10 Tage
Starlinger: Übernahme der Gewebesparte von Windmöller & Hölscher
Fakuma 2026: Nächste Ausgabe findet von Montag bis Freitag statt
Voelpker: Neuer Formaldehyd-Fänger - Unterdrückung von Kettenabbau und Formaldehydfreisetzung
Engel: „foammelt Days 2024“ am 27. und 28. November in Schwertberg - Schaumspritzgießen von A bis Z
Ernst Jäger Kunststoffverpackung: Insolvenzverfahren eröffnet - Eigenverwaltung angeordnet
Meist gelesen, 30 Tage
Dieffenbacher: Übernahme des Composites-Geschäftes von Schmidt & Heinzmann
Volkswagen: Mindestens drei deutschen Werken droht das Aus
Starlinger: Übernahme der Gewebesparte von Windmöller & Hölscher
Fakuma 2026: Nächste Ausgabe findet von Montag bis Freitag statt
Meist gelesen, 90 Tage
Arburg: Maschinenbauer erwartet deutlichen Umsatzrückgang
LyondellBasell: Neuer Kunststoff-Recyclingkomplex bei Gießen
Albis: Nachhaltige Kunststoffe für den Spritzguss und Extrusionsanwendungen im Fokus
New Albea Kunststofftechnik: Automobilzulieferer stellt Insolvenzantrag in Eigenverwaltung
Sumitomo (SHI) Demag: Personalabbau und strukturelle Veränderungen an deutschen Standorten
Dann veräußern Sie diese kostenlos
in der Rohstoffbörse.
Kunststoffe in der Medizintechnik
Das Fachbuch "Kunststoffe in der Medizintechnik - Vorschriften und Regularien, Produktrealisierung, Herstellungsprozesse, Qualifizierungs- und Validierungsstrategien" ist als Leitfaden für die Anwendung von Kunststoffen in Medizinprodukten konzipiert. |